a-Hyb Hybridization Station from Miltenyi Biotec
Northern BoundTM Human Alzheimer's Total RNA Blot from Sigma-Aldrich
...orning single use spatulas have been designed to s...hey are for those interested in eliminating the re...spatulas. Each spatula is individually packaged, R...kage: This CLS number is a new product number, cre...
...seful for the mechanical harvesting of cells &bull...ven contact with the growth surface • Designe...y wrapped • Sterilized by gamma radiation and...s a new product number, created to easily match Co...
Biology Products:(Date:11/24/2009)....24/PRNewswire-FirstCall/--Sigma-AldrichCorporatio...erenceonTuesday,December1stat1:45PMGMTinLondon,7:4...oadcastovertheInternetavailableat http://inve s ...Webcast"icontoaccessthisfile. ,, AboutSigma-A...Technologycompany.Itschemicalandbiochemicalproduct...
(Date:11/24/2009)...if.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(N...velopingandcommercializingnovelpainmanagementthera...ChiefExecutiveOfficer,isscheduledtopresentatthe21s...cember1-2,2009atTheNewYorkPalaceHotelinNewYork,New...ancialOfficer,willbeavailabletorespondtoquestionsd...
(Date:11/24/2009)...acyendpointhasbeenmetforpatientswithadvanced-stage...ov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NA...aceuticalcompanyfocusedonendocrinetherapyandoncolo...udywithitstargetedcytotoxicpeptideconjugate,AEZS-1...ntendometrialcancer.Inapersonalizedhealthcareappro...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth...enomicHealth,sExecutiveChairman,willpresentatthe21...ityonTuesday,December1,2009at10:00a.m.ET. ,, To...esentation,visittheInvestorRelationssectionofGenom...com .Pleaseconnecttothewebsiteatleast15minutesprio...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2